The Neurological Biomarkers market was valued at USD 6.92 Billion in 2022 and is expected to reach USD 21.45 Billion by 2030, growing at a CAGR of 13.4% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.